BioLineRx : Form 20-F/A (Amendment No. 1 -March 28, 2024 at

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20549


FORM 20-F/A




...

Related Keywords

United States , Israel , Modiin , Israel General , Washington , Israeli , American , Philipa Serlin , Kesselman , Securities Exchange , Biolinerx Ltd , International Financial Reporting Standards , Company Contact Person , Exchange Commission , International Accounting Standards Board , Pricewaterhousecoopers International , Companies Law , Company American Depositary , Israel Companies Law , Mark One , Securities Exchange Act , Ma Ayan Street Modi In , Depositary Shares , American Depositary , Interactive Data File , Regulations T , Financial Accounting Standards Board , Accounting Standards Codification , Sarbanes Oxley Act , Financial Reporting Standards , Accounting Standards Board , Exchange Act , Fiscal Year Ended December , Independent Registered Public Accountingfirm , Pricewaterhousecoopers International Limited , Original Report , Annual Report , American Depositary Shares , United States Dollars , New Israeli Shekels , Financial Review , Financial Condition , Ordinary Shares , License Agreement , Markets ,